Shares of Co-Diagnostics, Inc. (CODX) are up more than 5% in the morning trade on Monday at $6.29.
The molecular diagnostics company today said it has shipped testing reagents for monkeypox virus to one of its international distributors.
As of July 7, 2022, over 6,000 cases of monkeypox have been reported to WHO from 59 countries, the company said.
CODX has traded in the range of $3.66-$11.82 in the past 52 weeks.
Source: Read Full Article
Lates News:
-
FuboTV Gains 9% In Pre-market On Increased Q3 Revenue Outlook
-
Woman Targets Husband's Bitcoin in Novel Divorce Proceedings
-
Ethereum: Crypto Analyst Explains Why ‘$600 ETH Is Potentially in the Cards’
-
Cryptos Slide Ahead Of Jackson Hole Symposium
-
$940 Million in Bitcoin Move off Coinbase, Fueling Speculation a Whale Is Accumulating $BTC